194 related articles for article (PubMed ID: 17114083)
1. PET in face and neck tumours.
Rankin SC
Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
[TBL] [Abstract][Full Text] [Related]
2. [The rationale for imaging methods in head and neck oncology].
Westhofen M
Laryngorhinootologie; 2006 Oct; 85(10):720-2. PubMed ID: 17031762
[No Abstract] [Full Text] [Related]
3. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in cancer of the head and neck.
Hain SF
Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
[TBL] [Abstract][Full Text] [Related]
5. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
[No Abstract] [Full Text] [Related]
6. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Zollinger LV; Wiggins RH
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
[No Abstract] [Full Text] [Related]
7. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
[No Abstract] [Full Text] [Related]
8. Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Ekberg T; Sörensen J; Engström M; Blomquist E; Sundin A; Anniko M
Acta Otolaryngol; 2007 Feb; 127(2):186-93. PubMed ID: 17364351
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
Schwartz DL; Macapinlac HA; Weber RS
J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
[No Abstract] [Full Text] [Related]
10. The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Manolidis S; Donald PJ; Volk P; Pounds TR
Acta Otolaryngol Suppl; 1998; 534():1-11. PubMed ID: 9726577
[No Abstract] [Full Text] [Related]
11. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Pai M; Park CH; Suh JH; Koh JH
Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
[TBL] [Abstract][Full Text] [Related]
12. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
[TBL] [Abstract][Full Text] [Related]
13. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
15. Functional imaging in head and neck cancer.
Kutler DI; Wong RJ; Kraus DH
Curr Oncol Rep; 2005 Mar; 7(2):137-44. PubMed ID: 15717948
[TBL] [Abstract][Full Text] [Related]
16. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of image fusion from MR and PET in patients with head and neck cancer.
Nakamoto Y; Tamai K; Saga T; Higashi T; Hara T; Suga T; Koyama T; Togashi K
Mol Imaging Biol; 2009; 11(1):46-53. PubMed ID: 18769975
[TBL] [Abstract][Full Text] [Related]
19. The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
de Bree R
Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1653-5. PubMed ID: 20827553
[No Abstract] [Full Text] [Related]
20. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]